Combining Signal Peptidase and Lipoprotein Processing Inhibitors Overcomes Ayr Resistance in Staphylococcus aureus
Antimicrobial Agents and Chemotherapy · 2023
DOI: 10.1128/aac.00115-23 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, 2023. Verfasst von Madeleine C Stone und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Blavatnik Institute, Harvard Medical School, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Daptomycin, Staphylococcal Infections. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, HHS | National Institutes of Health.
Abstract (Originalsprache)
Antibiotic resistance in bacterial pathogens is an ongoing public health concern. The arylomycins are a class of natural product antibiotics that target the type I signal peptidase, which carries out the terminal step in protein secretion.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbiology, Blavatnik Institute, Harvard Medical School, Boston, Massachusetts, USA.
ORCID-Profile: Madeleine C Stone, Aaron Mychack, Suzanne Walker
Förderung
- NIAID NIH HHS
- HHS | National Institutes of Health
Zitieren
APA
Stone, M. C., Mychack, A., Coe, K. A., & Walker, S. (2023). Combining Signal Peptidase and Lipoprotein Processing Inhibitors Overcomes Ayr Resistance in Staphylococcus aureus. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.00115-23
Vancouver
Stone MC, Mychack A, Coe KA, Walker S. Combining Signal Peptidase and Lipoprotein Processing Inhibitors Overcomes Ayr Resistance in Staphylococcus aureus. Antimicrobial Agents and Chemotherapy. 2023. doi:10.1128/aac.00115-23
BibTeX
@article{Stone2023,
author = {Stone, Madeleine C and Mychack, Aaron and Coe, Kathryn A and Walker, Suzanne},
title = {Combining Signal Peptidase and Lipoprotein Processing Inhibitors Overcomes Ayr Resistance in Staphylococcus aureus},
journal = {Antimicrobial Agents and Chemotherapy},
year = {2023},
doi = {10.1128/aac.00115-23}
}
EUVIMED